Dr. Kurt Black Amgen Inc., USA

Kurt Black was the Scientific Director, Comparative Biology and Safety Sciences for Amgen Inc., where he was responsible for non-clinical safety assessment programs in the metabolic disorders therapeutic area. He was also involved in the development of the company’s approach to the toxicological assessment of impurities and metabolites and served... read moreon numerous cross-functional teams developing company-wide strategy for aspects of the chemistry, manufacturing and control of small molecule drugs. He had 20 years of experience in non-clinical safety assessment in the chemical, pharmaceutical and biotechnology industries. He sadly passed away in May 2018.